Relugolix approved in Canada for advanced prostate cancer ...Middle East

Health Canada has approved the oral GnRH receptor antagonist relugolix (Orgovyx ) for the treatment of patients with advanced prostate cancer.1 The approval is based on results from the phase 3 HERO study, which showed that 96.7% of patients randomized to relugolix maintained castration through 48 weeks, compared with 88.8% of patients receiving leuprolide (P 

Hence then, the article about relugolix approved in canada for advanced prostate cancer was published today ( Tuesday 24/10/2023 - 11:45 PM ) and is available on canadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Relugolix approved in Canada for advanced prostate cancer )

Also on site :

• Suburban teen charged in Near North hit-and-run wrong-way crash
• 100K+ acres destroyed as wildfires burn across Colorado
• Odisha Cabinet Approves 12 Key Proposals